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ABSTRACT  Studies of ancient DnA specimens started 25 years ago. At that time short mitochondrial DnA (mtDnA) fragments were the main targets in ancient 
DnA studies. the last three years were especially productive in the development of new methods of DnA purification and analysis. complete  mtDnA molecules 
and relatively large fragments of nuclear DnA are the targets of ancient DnA studies today. Ancient DnA studies allowed us to study organisms that went extinct 
more than ten thousand years ago, to reconstruct  their phenotypic traits  and evolution. Ancient DnA analyses can help understand  the development of ancient 
human populations and how they migrated. A new evolutionary hypothesis and reconstruction of the biota history have been re-created from recent ancient DnA 
data. Some peculiarities and problems specific to the study of ancient DnA were revealed, such as very limited amounts of DnA available for study, the short 
length of the DnA fragments, breaks and chemical modifications in DnA molecules that result in “postmortem” mutations or complete blockage of DnA replica-
tion in vitro. the same specific features of DnA analysis were revealed for specimens from complicated forensic cases that result in the lack of experimental data 
or interpretation problems..  
Here, we list the specific features of ancient DnA methodology and describe some achievements in fundamental and applied research of ancient DnA, including 
our own work in the field.
Keywords: ancient DnA, methods, evolution, DnA identification, forensic examination. 
Abbreviations:  mtDNA – mitochondrial DNA,  cmtDnA – complete mtDnA sequence, Str – short tandem repeats.
INTRODuCTION
Ancient DnA studies allow to empirically verify evolution-
ary hypotheses and contribute to the complex reconstruction 
of historical changes in biota. the analysis of DnA from hu-
man archeological samples reveals information on the genetic 
traits of ancient inhabitants of various geographical regions. 
the first published reports on the study of ancient DnA 
appeared 25 years ago. researchers managed to extract a 
DnA fragment from a museum sample of dried muscle tissue 
taken from a quagga – a South-African odd-toed ungulate 
animal that disappeared in the 19th century. the extracted 
DnA fragment was cloned in a phage vector and sequenced. 
Phylogenetic analysis showed that the determined sequence 
of the mitochondrial DnA (mtDnA) was related to zebra spe-
cies [1, 2]. the next study  described  the extraction, cloning, 
and sequencing of  DnA fragment from a ~2,400-thousand-
year-old egyptian mummy [3]. After these, attempts were 
made to extract DnA from the remains of animals, plants and 
microorganisms whose ages ranged from several hundreds to 
more than a million years (see review in [4]). As the data ac-
cumulated, it became clear that the age of the remains that 
could still have analyzable templates, calculated using  kinet-
ics of DnA decay,  was not greater than 0.1–1.0 Myr, and that 
the level of DnA preservation depended on the age and type 
of the biological sample, and also on the conditions in which it 
was preserved [5, 6]. reports on the extraction of DnA from 
specimens older than 1 Myr are most probably erroneous. the 
most ancient authentic DnA samples have been isolated from 
permafrost specimens, such as mammoth, bison and other 
animal remains, chloroplast DnA from plants, and bacterial 
DnA [7–12]. Fragments up to 900–1 000 base pairs (bp) have 
been amplified  from these samples. the low temperature and 
humidity improve DnA preservation, that allows researchers 
to analyze samples from remains that are tens of thousands of 
years old (Fig. 1) [13].
Studies of DnA isolated from ancient or historic specimens 
must deal with a number of methodical problems. these in-
clude the exceedingly small quantity and small size of the 
DnA fragments extracted from ancient samples, as well 
as the presence of chemical DnA modifications that block 
DnA  replication and cause the appearance of postmortem 
mutations in the nucleotide sequence. Spontaneous damage 
of  DnA molecules in a living  cell is repaired during replica-
tion or causes death and elimination.  After an organism dies, 
both the reparation and elimination of cells with damaged 
DnA come to a halt; that leads to the accumulation of chemi-
cal modifications and  fragmentation of DnA molecules. Fur-
thermore, the DnA is further destroyed  by the organisms of 
the soil biota. Degradation of ancient DnA makes contamina-
tion of the samples by even a single molecule of modern DnA 
a major cause of false results. 
using  the  Pcr techniques [14–16] has considerably wid-
ened the possibilities of ancient DnA analysis, since it allows 
in vitro amplification of a single original DnA molecule. Pcr 
allows selective amplification of target DnA fragments; that 
is very important in ancient DnA analysis, since 99% of the reVIeWS
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extracted DnA can be a mixture of  bacterial or fungal DnA 
from soil. 
the development of extraction and sequencing technolo-
gies in ancient DnA study in the past few years has  allowed   
to sequence the complete mitochondrial genomes, to  recon-
struct  nuclear genomic regions,  to analyze  the genetic popu-
lation variety of extinct species (moa, mammoth, furry rhi-
noceros, cave bear, Beringian bison, giant eagle, neanderthal, 
etc.), and to study changes in the Pleistocene and Holocene 
ecosystems (see reviews [4, 17–20]). 
Years of research have resulted in the establishment of a 
number of requirements to ancient DnA studies and criteria 
upon which the authenticity of resulting data is judged. con-
tamination of the analyzed samples by modern DnA is still 
one of the most pressing problems during ancient DnA anal-
ysis. One of the well-known examples is the report related to 
the extraction of a DnA fragment from the dinosaur bone 
[21] that, as it turned out during further analysis, was a frag-
ment of human nuclear DnA [22], as well as the mentioned 
above attempt to sequence DnA from an egyptian mummy 
[3]. currently, the sequence obtained in the mummy study is 
assumed to be the result of modern human DnA contamina-
tion [17, 23]. 
DnA sequences reconstructed from ancient or historic 
samples can also contain errors because of hydrolytic or ox-
idative modification of the ancient DnA. For example, se-
quencing of long regions of the same sample of neanderthal 
nuclear DnA was performed by two groups of researchers. 
the edward rubin group from the Joint Genome Institute 
of the u.S. Department of energy published a 65,000 bp se-
quence, and the Svante Pääbo group from the Max Planck 
Institute for evolutionary Anthropology reported the se-
quencing of 1 million bp [24, 25]. Further data analysis de-
termined that a considerable amount of errors was present 
in the second group’s data. Most of the data was the result of 
contamination by modern DnA. Furthermore, the “single-
run” sequencing approach used by this group did not prevent 
multiple errors that appeared because of ancient DnA nucle-
otide modification and could only be excluded by multiple se-
quencing [26–28]. errors were also detected in the published 
sequence of the mtDnA fragment from the Feldhofer cave 
neanderthal [29]. Out of the 27 detected alterations, as com-
pared to human mtDnA, 4 turned out to be artefacts [30]. 
the published nucleotide sequences of other species are also 
not free of errors  (the Pleistocene cave bear [31], mammoth 
[32, 33], etc.). 
Similar problems (exceedingly small amounts of DnA, or 
DnA damaged by thermal conditions or chemical agents) of-
ten come up during the genetic analysis of forensic samples. 
An analysis of these problems and approaches that allow to 
solve them are presented in this review.
ExTRACTION OF DNA AND CONTAMINATION PROBLEM
Paleontological and archeological materials and biological 
samples that are collected at excavation sites or stored in 
museums yield very small amounts of DnA that is usually 
highly fragmented. Moreover, this ancient DnA is modified 
in various ways that prevents amplification or lead to errors 
in nucleotide sequence reads. Because of the low efficiency of 
amplification of authentic DnA extracted from ancient and 
historic samples, contamination of the sample by even a sin-
gle modern DnA molecule can produce errors. A number  of 
specific measures must be taken in order to prevent contami-
nation and to detect possible contamination. False positive 
results, caused by in-lab contamination, are one of the major 
problems in ancient DnA studies. that is why the key step in 
molecular-genetic analysis of ancient and historic samples is 
DnA extraction. 
extraction of DnA from ancient samples must be per-
formed in accordance with sample  age and quality. It par-
ticularly involves the choice of the detergent used for cell 
lysis. Sodium dodecyl sulfate (SDS) that is used in standard 
DnA extraction for the purpose of lipid destruction could be 
substituted by non-ionic detergents for soft lysis (triton or 
twin), or by detergent-free extraction, since lipids have been 
already destroyed in ancient samples, and the use of SDS 
lowers the DnA yield. nevertheless, the use of detergents is   
recommended  for more recent samples. treating bone mate-
rial with reagents that include eDtA causes sample decalci-
fication and  pH lowering, which can affect DnA binding on 
the columns used in downstream extraction procedures. 
Studies of ancient DnA should be conducted in specially 
equipped facilities with all possible means for preventing con-
tamination by modern DnA. It includes facilities with altered 
air pressure: high pressure in the rooms used for ancient 
DnA work and low pressure in rooms where modern DnA 
and amplified products are studied. these facilities must be 
regularly disinfected with chemicals and uV-radiation, to 
avoid  any DnA (target, amplified or contaminant) and cell 
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Fig. 1. Unusually well-preserved mammoth M. primigenius DNA speci-
men obtained from permafrost-preserved remains found in 1986  in the 
valley of the Enmynveem River (Chukotka): 
а – Fluorescence of nuclei in muscle cells of M. primigenius (~33, 000 
years old) after DAPI staining  indicates a relatively high degree of  DNA 
preservation;   b – electrophoresis of total genomic DNA extracted from 
mammoth muscle tissue  (lane 1  is 1/10 dilution of the DNA on lane 2), 
and control  DNA isolated  from fresh human blood samples (lanes 3 
and 4). The right lane is a DNA molecular weight marker (fragments sizes 
are  indicated in kb) [13]60 | ActA nAturAe |  № 3 2009
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material  (aerosols and dust with microorganisms and human 
and other organism’s cells). Ancient DnA work must be con-
ducted in protective clothing, gloves, and masks. A minimum 
requirement is that DnA extraction procedures performed 
on ancient DnA and involving single fragmented molecules 
must be performed in facilities physically separated from the 
ones for Pcr-amplification and downstream amplified DnA 
procedures that work with millions of molecules. Facilities 
for ancient DnA handling must not house procedures with 
amplified fragments, as it is exceedingly difficult to prevent 
their spreading. DnA from modern organisms must be han-
dled in a separate building, or at least a facility with a sepa-
rate ventilation system. All these measures help  to prevent 
contamination but do not affect the contamination of the 
sample itself that remains as it was before it ever got into the 
laboratory. In order to decrease contamination, the surface 
layer of the sample is usually removed. 
contamination is usually a very important issue in ancient 
human or microbal DnA studies, since both human and bac-
terial DnA are constantly present in laboratory. thus, the se-
quences of contaminant DnA are harder to separate from the 
authentic DnA than when dealing with exotic or rare species. 
the guidelines for working with ancient DnA and the crite-
ria of authenticity for the amplified ancient DnA fragments 
are described in the following reviews [4, 17, 34–36] and are 
listed in table 1.
Table 1.  Authenticity criteria for ancient DNA
criteria Importance for authenticity
reagents and plastic to be used for work with ancient DnA must be 
tested  for potential contamination (possible presence of amplifiable 
foreign  DnA  templates in any reagent). contamination of the laboratory 
material by only single DnA molecules can occur, thus the contaminating 
DnA molecules  may yield amplification Pcr product in only one out of 
several tested samples. thus  multiple control tests have to be performed 
for the  laboratory reagents and material. 
Prevents contamination through reagents and disposable materials.
All the manipulations for DnA extraction are performed for the control 
samples using in parallel  the same solutions, but  with no ancient mate-
rial added in a course of the procedures. thus Pcr is performed with a 
double negative control: the regular “Pcr control”  (Pcr mix with no 
extracted DnA template) and the  extraction control (Pcr mix with the 
“empty” extract).
Helps to detect contamination that may happen during extraction or  in a 
process of  the Pcr mix preparation.
Positive controls are usually not used to avoid the risk of potential cross- 
contamination of the tested samples. Prevents contamination.
Whenever possible, several independent extractions of DnA are per-
formed using different samples from the same specimen.
Helps to identify the authentic endogenous DnA if local contaminations by 
external DnA occurred on the tested specimen  itself.
repeated Pcr amplifications of material obtained from the same and 
from different extractions.
Helps to identify sporadic contamination; facilitates the identification of 
potential errors due to Pcr errors  or chemical modifications of ancient DnA 
templates (“postmortem ancient DnA mutations”); control the phenomenon 
of drop-out or drop-in alleles (heterozygous and homozygous state) occurring 
in Pcr of very low amount of DnA ( low copy number DnA templates)  
 cloning of amplification products and sequencing of multiple clones.
Identifies heterogeneity in the amplified products caused by  contamination 
with  foreign DnA or incorporation of postmortem DnA mutations due to 
chemical modification of  ancient DnA templates nucleotides.
Quantification  of the number of original DnA template molecules taken 
for each Pcr. the minimal amount of DnA templates required can   
vary noticeably depending on the length and the nucleotide content of 
the amplified fragment, and also on the sensitivity of the specific pair 
of primers. 
Determines the possibility that nucleotide errors occasionally generated 
during the initial rounds of Pcr  will exist in the majority of the molecules 
in a final Pcr product and thereby, the consensus sequence may harbor 
the errors. extracts that contain only a few or even a single molecule are 
very much prone to yield this type of errors. to avoid them  several inde-
pendent amplifications are required to determine the authentic sequence.   
Amplification using at least 1 000 original DnA molecules in Pcr most likely 
yield the correct consensus  sequence in each nucleotide position.
Peculiar “molecular behavior,”  a reverse correlation between the effi-
ciency of amplification and the length of the amplified fragment.
If the sample does not exhibit more intensive amplification of shorter frag-
ments than that of longer fragments, as compared to modern DnA, this 
indicates that the source of the amplified DnA is contaminated by modern 
templates. 
Biochemical analysis of the level of preservation of macromolecules.
A high level of biochemical preservation of macromolecules indicates a high 
probability of preserved DnA molecules being found in the sample. thus, 
the test would support the authenticity of the DnA sequencing results. 
careful design of Pcr primers for authentic mtDnA sequences to avoid   
concurrent Pcr amplification of nuclear pseudo mitochondrial DnA 
(numt) sequences along with   mtDnA regions.
nuclear genome has regions of multiple insertions of  mtDnA regions 
diverged during  the evolution. thus the  amplification of nuclear pseu-
dogenes instead or along with mitochondrial DnA sequences could be 
potentially obtained  for certain Pcr primers designed for amplification of 
mtDnA genome sequences. 
Independent confirmation of results in a different laboratory.
It may help to identify laboratory contamination of samples or reagents, 
but it does not rule out contamination that can occur in the sample itself 
(contaminants that were a part of the sample before it arrived at the labora-
tory, for instance during archeological excavation). the requirement for two 
independent laboratories involved in DnA extraction and primary analysis 
was mandatory. now it has been dropped. reVIeWS
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IDENTIFyING CONTAMINATION
Possible contamination can be identified  with a high degree 
of accuracy during ancient DnA studies if it is a priori  sup-
posed that the sample could be contaminated, so that the 
results are viewed with this possibility in mind. In order to 
identify laboratory contamination, researchers use “empty” 
extracts that have been processed along with the target sam-
ple but without  adding tissue sample or DnA. Since contami-
nation templates can be present in very low concentrations 
and  not manifest themselves in each reaction, multiple con-
trol reactions are made, usually in proportion 1:5 , but with 
no fewer than 1:1 to the extracted sample. Such “empty” ex-
tracts are used in all further analytic procedures in addition 
to the regular negative controls. 
Independent confirmation of results in  different laborato-
ries  is considered to be one of the strong indicators of authen-
ticity. But even this is not an absolute guarantee [36]. 
Special attention must be paid to bioinformatic analysis 
of the obtained nucleotide sequences. Since analysis of an-
cient samples usually involves mtDnA analysis, it is impor-
tant to compare the sequence not only with the mtDnA of 
species closely related to the sample source or with human 
mtDnA (the most likely source of contamination), but also 
with the nuclear homologues of mtDnA genes (nuclear mtD-
nAs, numts), whose similarity to mtDnA is ~98% and more in 
case of human mtDnA (such as the nt_004350.18 sequence 
located on chromosome 1).
CHEMICAL MODIFICATIONS OF ANCIENT 
DNA AND POSTMORTEM MuTATIONS 
Postmortem DnA alterations, and mutations during in vitro 
DnA amplification, are among the central methodological 
problems in ancient DnA and complex forensic DnA analy-
sis. As opposed to metabolically active tissues that have an 
active DnA reparation system postmortem cells accumulate 
chemical (hydrolytic or oxidative) DnA modifications and 
strand damage. Studies show that postmortem DnA dam-
age includes strand breaks, loss of bases and cross-linking 
between strands that inhibits Pcr. Postmortem alterations 
that modify bases but do not inhibit amplification are espe-
cially important, since they can cause the appearance in the 
amplification products nucleotide of changes that were not 
present in the authentic sequence  (type I substitutions A → 
G / t → c and type II substitutions c → t / G → A) (table 2). 
the manner how the degraded DnA templates are damaged 
depends on the samples age, their geographic origin, and the 
taphonomic conditions (preservation conditions) of the en-
vironment where the samples were stored. Postmortem al-
terations can appear in mutational hot-spots, thus simulating 
evolutionary mechanisms [37]. the manner and dynamics of 
accumulation of postmortem DnA alterations are under con-
tinuous research [38, 39]. DnA damage limits the size of the 
DnA fragments found in ancient samples to about 100–500 
Table 2. Various types of ancient DNA damage (from [4, 17] with modifications)
type of damage cause of damage effect on DnA Possible solution 
nucleobases and deoxyribose 
degradation
Postmortem destruction 
by intracellular nucleases, 
degradation by microorganisms 
and environmental  chemical 
processes 
Apurinization of DnA, strand 
breaks, decrease of DnA frag-
ment size, decrease of the overall 
amount of DnA
Amplification of short (<100–200 bp) over-
lapping fragments
cross-links that block Pcr
Alkylation, Maillard reaction 
(chemical reaction between a 
sugar  molecule and an amino 
group of a nucleobase or an 
amino acid)
cross-links between DnA strands 
in a single molecule; cross-links 
between DnA strands of different 
molecules; or cross-links between 
DnA and proteins 
treating the sample with reagents that 
destroy cross-links 
Deamination and other types 
of oxidative or hydrolytic 
DnA  base modifications 
Adenine –> hypoxanthine
Guanine –> xanthine
cytosine  –> uracil
5-methyl-cytosine –> thymine
Insertion during amplification of 
nucleotides that were not present 
in the original nonmodified 
template
treatment by DnA uracil-n-glycosylase that 
removes cytosine deamination products.  
Determination of a consensus sequence 
based on multiple sequencing of the analyzed 
regions: Multiple independent Pcr, cloning 
of the original template or Pcr products, and 
sequencing several clones 
-10.0
10.0-
CYTB
M-11
M-30
M-20
M-22
M-27
ND5
ATP6
-3.0
3.0-
-2.0
-1.5
1.5- -1.2
  1.0 1.0-
-0.5 0.5-
0.1-
-0.1
М
М
КК
а b
Fig. 2. A typical result of PCR amplification of mammoth mitochondrial 
genome fragments:
a – PCR products of relatively short amplification fragments (300–600 
bp); b – Successful amplification of long PCR fragments harboring entire 
mitochondrial gene sequences (1317 bp for the CytB gene and 1613 
bp for the ATP6 gene) and no amplification products are  obtained for  
larger size PCR fragments  (3054 bp for the ND5 gene). М –marker frag-
ment  sizes  are indicated in kb, К – negative controls  [13]62 | ActA nAturAe |  № 3 2009
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bp. that is why the primers for ancient DnA Pcr are usu-
ally chosen for no more than 200-300 bp fragments, although 
fragments of greater length have been obtained in some cases 
(Fig. 2). 
Most of the published ancient DnA studies have been con-
ducted on mtDnA that  is found in hundreds and thousands 
of copies in cell and can be amplified more successfully than 
nuclear DnA. there are much fewer studies on nuclear DnA. 
Amplification, cloning, and sequencing of nuclear DnA from 
a mammoth M. primigenius sample obtained from chuko-
tka permafrost was performed in order to assess the quality 
of nuclear DnA preservation (e.I. rogaev, e. rubin, unpub-
lished data). Most of the mammoth genome was fragmented 
into pieces of about 50–100 bp (Fig. 3). It  indicates a relatively 
high quality of nuclear DnA preservation.
Postmortem modifications are randomly located in the 
preserved DnA fragments. For example, single nucleotide 
substitutions (~ 6 in 1 000 bp) were found in one study [13] 
during the cloning and sequencing of Pcr-amplified mam-
moth DnA. this observation was taken into account for  cor-
rect reconstruction of  the complete  mitochondrial genome   
of chukotka mammoth M. primigenius (Fig. 4).  the complete 
genome was obtained as a consensus of multiple overlapping 
fragments [13]. In order to additionally control the number of 
postmortem mutations, the overall number of substitutions 
in all mammoth mtDnA genes was calculated in  comparison 
with elephant E. maximus mtDnA. the ratio between non-
synonymous (that cause aminoacid substitutions) and syn-
onymous substitutions was calculated for the same purpose. 
It was shown that the number of substitutions in the mtDnA 
genes of the chukotka mammoth [13] was lower than in the 
genes of a mammoth sequence obtained from remains found 
in Yakutia that was published at the same time by German 
researchers [40]. A comparative analysis showed that this dif-
ference was due to the unusually high number of substitu-
tions in a 200-300 nucleotide region of the Yakut mammoth 
DnA in the locus of  ND1 and ND2 genes, and that the num-
ber of nonsynonymous substitutions was greater than the 
number of synonymous ones (2:1 for the ND1 gene and 7:2 
for ND2). the ND2 gene of the chukotka mammoth had only 
one synonymous substitution, and ND1 did not differ in any 
way from the elephant gene [13]. All undetected postmortem 
mutations affect the result of phylogenetic reconstruction. 
NOVEL DNA-SEquENCING TECHNOLOGIES
Ancient DnA analysis involves sequencing of a large number 
of short fragments that have multiple overlapping  of  the 
same genomic regions. Low sequencing speed  and high cost 
limit the usage of such research. novel technologies of  mas-
sively  parallel sequencing of a large amount of DnA samples 
have appeared in the last 3-4 years, and the cost has dropped 
by two orders of magnitude. this novel technologies have giv-
en researchers sequencing possibilities that were previously 
available only to large genomic centers. Among the available 
novel technologies several were used  in ancient DnA studies, 
such as clonal amplification followed by parallel sequencing 
of dense micropanels of cloned DnA fragments by repeated 
enzymatic reaction cycles, with automatic registration of the 
signal from each cycle and  every fragment.
the ordered spatial localization of the Pcr amplicons on a 
chip or immobilization on microne-sized beads that are then 
placed into ordered cells allows to minimize the reaction mix 
volumes, thus decreasing the cost of the whole process. 
realization of these strategies involves several steps, and 
for each of them a specific technical approach has been de-
veloped. For example, preparation of DnA fragment libraries 
using Pcr does not keep the ratio of amplification products 
identical to the ratio of  original templates. Some DnA frag-
ments are amplified more efficiently than others that  could 
be lost. the problem can be solved  by using emulsion Pcr. 
Fig. 3. The size distribution of genomic DNA fragments extracted from 
the ancient remains  sequenced on the 454 platform. Unpublished data 
obtained in collaboration of E.I. Rogaev et al. with M. Blow and E. Rubin
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Fig. 4. Mitochondrial genome of the woolly mammoth M. primigenius. 
Determination of the nucleotide sequence of the complete mitochondrial 
genome was performed in two  laboratories. The overlapping PCR-am-
plification products used for sequencing are shown in the inner circle [13]
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the DnA solution  is transferred  into the  mineral oil mix. 
the ratio  is calculated so that each molecule of DnA is en-
capsulated in a separate lipid  droplet that acts as a microre-
actor for the amplification process. this approach minimizes 
the loss of certain original templates. there are various tech-
nical solutions for fragment library preparation and for the 
other steps in the process, such as enzymatic reactions, visu-
alization and computerized signal registration, data storage 
and analysis [41]. 
novel sequencing technologies have certain limitations. 
Massively parallel pyrosequencing, accomplished  by using   
454 Life Science system (Genome Sequence 20tM DnA se-
quencing System: GS20, roche/454 Life Science), provides 
a 100-fold increase in the sequencing speed, compared to the 
standard capillary electrophoresis method. up to 25 million 
nucleotides are analyzed in a single run. Only a short sequence 
can be read (usually less than 250–400 bp). It is not much of 
a limitation for ancient DnA studies, since most  of  the DnA 
fragments are precisely of this size.. 
the Illumina technology, named Solexa (after the name of 
the company that developed this approach), and SOLiD (ABI 
corporation) allow the analysis of up to 1 billion nucleotides 
in a single run but read sequences of only 30–40 nucleotides 
(last year this number was just 25 nucleotides). the avail-
ability of full human genomes and the genomes of commonly 
used model organisms as reference sequences allow to map 
the short fragments into a single contig. 
Another limitation of these novel platforms is the 10-fold 
decrease in the accuracy of  sequencing, compared to the 
Sanger method. nevertheless, these technologies are very 
promising, and they can be expected to improve in efficiency 
and quality in the nearest future. 
ANALySIS OF DEGRADED DNA IN FORENSIC 
ExPERTISE OF HISTORIC SAMPLES
the technological approaches applied for  ancient DnA 
study  can also be used for forensic genetic analysis in dif-
ficult cases where only microscopic amounts of material are 
available or the DnA has been severely damaged. Some of 
these approaches were used in the genetic expertise of the 
putative remains of the family of the last russian emperor 
nicholas II romanov. In the early 1990s, a first grave with 
human remains was found near Yekaterinburg. During the 
investigation, it was suggested that the remains belong to the 
family of the russian emperor nicholas II romanov, his wife, 
the empress Alexandra Fedorovna, their 3 daughters, the 
court physician, and three servants. they are all thought to 
have been murdered  in 1918 [42–44]. However, the remains 
of two children of the romanov family were not  identified, 
and their fate remained unknown. Among other hypothe-
ses, there has been a legend that Alexey and Anastasia, the 
youngest children of the romanov family, had survived those 
turbulent  times. In July 2007, a second grave was found not 
far from the first one. It contained burned bone fragments 
from two skeletons. Forty-four bone fragments were found 
in the second grave, all severely damaged by fire and pre-
sumably sulfuric acid. Preliminary anthropological analysis 
of the half-burned bone fragments from the second grave 
suggested that the bones belonged to a boy 10-14 years of age 
and a young woman of about 18–23.  the least damaged frag-
ments of the femoral bones from both the male and female 
skeletons were selected for genetic analysis, and they were 
labeled Samples 146 and 147, respectively. Samples from the 
first grave  were also collected for a more detailed study, and 
reference samples were taken from living relatives of nicho-
las romanov and Alexandra Fedorovna. Furthermore, swabs 
of blood stains from a shirt that had belonged to nicholas II 
and is stored in the Hermitage museum were also used for 
analysis. the study included the following steps: preparation 
of the samples for DnA extraction; DnA extraction; quanti-
fication of the extracted total DnA and human-specific DnA; 
amplification and sequencing of the mitochondrial hyper-
variable regions, and later sequencing and  reconstruction of 
the  complete mtDnA (cmtDnA) sequence; determination of 
the Str-profiles of the Y-chromosome; determination of the 
autosomal Str-profiles; additional sex identification with the 
use of a special marker designed  for degraded DnA analysis 
[45, 46]; and extraction and analysis of modern DnA from 
romanov family relatives and their comparison to historic 
samples. the steps and methods of DnA identification  are 
described in table 3 [45]. 
MITOCHONDRIAL GENOME ANALySIS
complete nucleotide sequences of the mitochondrial genome 
have been determined for the putative remains of nicholas 
II and Alexandra Fedorovna from the first grave; and the 
putative remains of Alexey and his sister, from the second 
grave. the mitotypes of the putative remains of  nicholas II 
and Alexandra Fedorovna are from the common european 
mtDnA haplogroups t2 and H1.
complete cmtDnA sequences were also determined for 
the relatives  of Queen Victoria (1819–1901) for 2 maternal 
lineages, the descendants of princess Victoria, sister of Al-
exandra Fedorovna, and their aunt Beatrice (Fig. 5). their 
cmtDnA were absolutely identical with those extracted from 
the putative remains of Alexandra Fedorovna and the 2 chil-
dren from the second grave. Searches performed in the avail-
able cmtDnA databases (table 4) showed that not one of the 
available tens of thousands of sequences identifies with this 
cmtDnA, which was named “Queen Victoria mitotype.” thus, 
the first and second burial sites really do contain the remains 
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Fig. 5. Maternal lineages of Empress  Alexandra Fedorovna.  
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of Queen Victoria’s granddaughter, great granddaughter, 
and great grandson. 
Determination of the cmtDnA from the putative remains 
of nicholas II confirmed the earlier described heteroplasmy 
(the coexistence of several mtDnA types) at the 16169c/t 
site. Moreover, nucleotide substitutions were found in the 
coding region of the mtDnA, including the extremely rare 
2850c variant in the 16S rrnA gene (population frequency 
approximately 0.004).  nucleotide substitutions in the mtDnA 
from the putative remains of nicholas II and from the blood 
stains on the shirt were completely identical [45]. the ratio 
between the heteroplasmic mtDnA variants was similar both 
in the remains and in the blood. nicholas II’s brother, George, 
whose remains were studied previously, also had heteroplas-
Table 3. Methodical approaches specific to analyses of degraded DNA from historical specimens[45]
Stage of analysis Special procedures reagents and methods
Preparation of histori-
cal samples
Independent analysis in specialized laboratories in VIGG 
(Moscow) and university of Massachusetts Medical 
School (Worcester, uSA).
Physical and chemical cleaning of small bone fragments, 
crushing or drilling to obtain bone powder.
extraction of DnA 
from bone specimens
All the experimental procedures were performed in ster-
ile Pcr-hoods, in accordance with standards for ancient 
DnA research,  with all the safety precautions, avoiding  
contamination  of  the samples by modern DnA. 
DnA was extracted from ~170–750 mg of cleaned bone material 
treated by 0.5 М eDtA and proteinase K and was then purified 
by a QIAquick Pcr purification kit (Qiagen) in accordance with 
the manufacturer’s protocol with minor modifications.
extraction of DnA 
from archival  blood-
stains 
the biological material was obtained from 4 different 
blood stains. At least 3 swabs were taken from each spot. 
In order to minimize contamination, DnA was extracted 
only from the 2nd and 3rd swabs for each spot.
DnA was extracted with the QIAamp DnA Mini Kit (Qiagen) 
using the manufacturer’s protocol (“DnA Purification from 
Dried Blood Spots”) with our own modifications.
Quantification DnA 
analysis
the total extracted DnA was quantified by the Quant-it™ 
PicoGreen® Assay kit (Invitrogen), human specific DnA was 
quantified by the Plexor® HY assay kit (Promega) and the 
7500 real-time Pcr System (Applied Biosystems).
Sequencing of HVr1 
and HVr2 of mtDnA 
from historical samples 
Potential contamination by foreign DnA was monitored  
by using negative controls (amplification of “empty” 
extracts and Pcr without addition of the template).
mtDnA fragments were amplified as short overlapping 
fragments. the Pcr products were then extracted from the 
agarose gel using a QIAquick Gel extraction kit or a Minelute 
Gel extraction kit.  For additional studies, the Pcr products 
from  some specimens  were cloned.
Sequence analysis of 
the complete mitochon-
drial genome, extracted 
from bone specimens.
Since the DnA was highly degraded, short overlapping 
fragments sized 164-383 bp were obtained, covering 
whole mitochondrial genome. 
Because the amount of DnA was limited, multiplex amplifica-
tions were performed using 88 pairs of specially designed 
primers grouped into 3 sets, and then the products of the  first 
Pcr rounds were amplified with individual primer pairs. the 
secondary Pcr products were then sequenced using three 
different strategies 
Analysis of the mtDnA 
extracted from the 
blood stains on shirt 
that belonged to 
nicholas II.
extraction of DnA was performed from different swabs 
from at least 3 shirt blood stains.  up to 5 or 7  Pcr repli-
cations  were conducted for some of the mtDnA SnPs to 
identify the potential heterogeneity and contamination 
by other individuals and selection of the extracts  pre-
senting mitotype  likely from one individual only.
Since the quality of preservation in the blood stains was 
unknown, initially a set of primers was developed for the 
amplification of short (64–109 bp) DnA fragments that would 
include very rare SnPs identified in the previous analysis of 
Skeleton №4 (the putative skeleton of nicholas II). 
extraction and analysis 
of DnA from modern 
samples.
For modern DnA analysis all the procedures were 
performed in separate buildings, physically separated 
from the ancient DnA laboratories. Informed consent was 
obtained from all living relatives participating in the study.
DnA obtained from buccal swabs or drops of blood was 
extracted using standard protocols. Pcr was performed using 
a set of primers for amplifying longer fragments.
Assembly of fragments 
into a continuous 
nucleotide  sequence 
(contig).
the sequences were assembled using Seqman software, 
DnAStAr, and the revised cambridge reference sequence 
(rcrS, accession number Ac_000021) as a standard.
Sex identification.
Sex was identified using the standard method, amplification 
of a fragment of the amelogenin gene using several com-
mercial kits: AmpFlStr® MiniFiler™ (Applied Biosystems) 
and PowerPlex S5 (Promega). Specially designed primers for 
the amplification of short fragments specific to the X- and 
Y-chromosomes were also used. 
Analysis of nuclear 
Str markers.
mtDnA or nuclear DnA extracts that consisted of a mix 
of individual profiles were discarded from further analy-
sis. each sample from various extracts was amplified in 
multiple replications.  Homozygous loci were considered 
authentic if multiple independent amplifications con-
firmed a certain allele for the autosome Str-marker. 
the following kits were used in order to obtain autosomal 
Str profiles from bone samples of the first and second burial 
sites: AmpFlStr® MiniFiler™ Pcr Amplification Kit (Applied 
Biosystems) and PowerPlex S5 System (Promega), specifically 
designed  for analyzing degraded DnA.
Str-profiles of the Y 
chromosome.
the AmpFlStr® Yfiler™ (Applied Biosystems) kit was used, 
according to the manufacturer’s protocol with minor modifica-
tions for analysis of degraded DnA.
electrophoresis analysis 
In order to increase the signal intensity and lower “noise” 
in the Str-profiles, the products of multiplex amplifica-
tion were sometimes purified with  Qiagen Minielute 
columns. 
electrophoretic analysis was performed using a 96-capillary 
sequencer 3730xl DnA Analyzer (Applied Biosystems). the 
results were analyzed with GeneMapper ® ID software v3.2 
(Applied Biosystems).reVIeWS
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Table 4. Databases used for analyzing  the population frequencies of the determined genetic profiles [45, 49]
Query sequence
number of 
samples in the 
database
name of the database
complete  
mitochondrial 
genome 
71,664
2,704
14,486
Mitosearch (www.mitosearch.org) contains sequences of the hypervariable region;    
mtDB, Human Mitochondrial Genome Database (www.genpat.uu.se/mtDB);  
eurOS, our own database, compiled from our own and other authors’ published data for the uSSr and 
russian populations and for certain european populations (German, english, etc.).
Str-haplotype of 
the Y-chromosome
4,163
1,261
u.S. consolidated Y-Str Database  has genotypes for 15-17 Y-Str loci (http://www.usystrdatabase.org/);
Data for russians from the Y chromosome Haplotype reference Database (YHrD, www.yhrd.org/index.html).
Autosome Strs > 50,000 For this study we combined the non-overlapping data for european populations from two large databases: 
ALFreD (http://alfred.med.yale.edu/alfred/) and the Distribution of the Human DnA-Pcr Polymorphisms 
database (http://www.uniduesseldorf.de/WWW/MedFak/Serology/database.html) and also added the 
recently published data on the russian population.
Mutation  in the 
IVS3-3 position of 
the F9 gene
Population SnP database (ncBI, HapMap Project);
~ 928 X-chromosomes of healthy individuals of european descent whose genotypes were assessed for this 
SnP using Pcr-rFLP (restriction Fragment Length Polymorphism) especially for this study; 
Hemobase: Hemophilia B mutation registry,  Haemophilia B mutation database.
Table 5. STR-haplotype analysis of  the Y-chromosome [45]
Markers № 4 № 146
Members of 
the romanov 
family
Archive 
blood stain 
from a shirt
control 
DnA
ABI, 007
DYS456 16 16 16 16 15
DYS389I 13 13 13 13 13
DYS390 24 24 24 24 24
DYS389II 29 29 29 29 29
DYS458 17 17 17 17 17
DYS19 14 14 14 14 15
DYS385 11, 14 11, nD 11, 14 11, 14 11, 14
DYS393 13 13 13 13 13
DYS391 10 10 10 10 11
DYS439 11 11 11 11 12
DYS635 24 24 24 24 24
DYS392 13 13 13 13 13
Y-GAtA-H4 12 12 12 12 13
DYS437 15 15 15 15 15
DYS438 12 12 12 12 12
DYS448 19 19 19 19 19
my at the same site [43]. the descendants of Kseniya, sister 
of nicholas II, had the homoplasmic 16169 t variant, and the 
previously performed mtDnA study of nicholas II’s sister’s 
son found the homoplasmic 16169c variant [44]. not one of 
the reconstructed complete mtDnA sequences (“Dagmar” 
type) was identified in  available databases (table 4), which 
confirms the assumption that the studied remains belong to 
nicholas II. the data suggest that the brothers nicholas II and 
George romanov inherited heteroplasmy from their mother 
Maria Fedorovna (Princess Dagmar), and that her descend-
ants had this heteroplasmy segregated into two distinct mtD-
nA variants in two generations. the nucleotide substitution 
at position 16169, on which the heteroplasmy of the “Dagmar 
type” is based, is located in the noncoding (hypervariable) re-
gion of the mtDnA characterized by increased polymorphism 
compared to the coding regions. the population frequency 
of heteroplasmy for point substitutions in hypervariable re-
gions averages 6% [47]. It is assumed that rapid segregation of 
heteroplasmic mtDnA variants in descendants is caused by 
mechanisms of biological “bottle-neck” (a massive decrease 
in the number of mtDnA copies) during oocyte maturation in 
the postnatal folliculogenesis in mammals [48].
NuCLEAR STR-MARKER ANALySIS
to study the paternal lineage  DnA profiles of the putative 
remains of emperor nicholas II and Prince Alexey, the Str-
haplotypes of the Y-chromosome were determined. Special-
ized procedures were developed in order to increase the Pcr 
sensitivity, since the amount of the available DnA was lim-
ited, and the molecules were highly fragmented (some of the 
methods are described in table 3) [45]. the Str-profiles were 
determined from multiple independent Pcr amplifications   
using no less than three different DnA extracts. Only the al-
leles that were identified in no less  than 2 amplifications were 
considered authentic. A full Y-Str profile for the bone speci-
men of Skeleton №4 and for the museum samples of nicholas 
II’s blood was obtained using these criteria. Low-copy high-
ly fragmented DnA often loses  single Str alleles. Marker 
DYS385 shows two loci on the Y-chromosome. the high mo-
lecular weight allele (DYS385/ 14) was identified only once 
in the repeated experiments with the DnA extracted from 
Sample #146, thus this allele for Sample #146 is indicated  as 
not determined (nD). DnA isolated  from the archival  nicho-
las II  bloodstain and DnA obtained  from romanov  paternal 
lineage family members were used as reference samples (Fig. 
6). Y-chromosome Str-profiles of the studied samples and 
the reference sequences were completely identical (Fig. 7 and 
table 5). this 17-locus Y-Str haplotype is unique. It is not 
found in large population databases for multi-locus Y-Str 
(table 4) and was first encountered in the described study 
[45].
Further gender and autosomal chromosome genotyping 
with Str multiplex systems developed especially for de-
graded DnA demonstrated that the male (Sample № 146) 
and the female (Sample № 147) from the second grave have 66 | ActA nAturAe |  № 3 2009
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autosomal Str profiles  nonidentical to any  Str profiles  de-
termined for  romanov family remains from the first grave 
but consistent with a biological kinship connection (Fig. 8). 
these data clearly demonstrate that these newly found re-
mains may belong to Prince Alexey and one of the daughters 
of the imperial family. the available nuclear DnA analysis 
data, supported by the anthropological data, prove that the 
remains from the second grave belong to a young woman (№ 
147) and a boy (№ 146), and that samples from the second 
grave are not from Skeleton № 7 (putative mother, empress 
Alexandra Fedorovna) or Skeleton № 4 (putative father, em-
peror nicholas II); however, they are related through the pa-
ternal and maternal lineages.
the statistical evaluation (likelihood ratio) based on three 
identification approaches for determining whether the bones 
belong to nicholas II, and not to any other random individual, 
is on the order of  a septillions  (> 1026) [45].  taken together 
our data establish  beyond reasonable doubt  that the studied 
remains belong to the last russian emperor nicholas II ro-
manov, his wife the empress Alexandra Fedorovna, their 4 
daughters (the Grand Duchesses Olga, tatiana, Maria, and 
Anastasia), and their son (Prince Alexey). 
HEMOPHILIA: SEARCH FOR MuTATIONS IN THE 
GENES FOR BLOOD CLOTTING FACTORS
there is historical evidence  that Prince Alexey suffered from 
severe bleeding that is characteristic of hemophilia. It is now 
known that hemophilia is caused by insufficient activity of 
blood clotting factors. Factor VIII deficit caused by mutations 
in the F8 gene is the cause of the most common hemophilia A 
(about one in 5 000 boys is born with this disease), and Fac-
tor IX deficit causes hemophilia B (F9 gene), which occurs 5 
times less often.  
A few hundred mutations that cause hemophilia have 
been described to this day. Both of the blood clotting factor 
genes are localized on the X-chromosome; that is why males 
carrying the mutant gene exhibit the disease. Females carry-
ing a single copy of the mutant gene and a copy of the normal 
one are healthy in most cases, although  some of them (10 %) 
can exhibit decreased efficiency of blood clotting. Females 
can be assessed for hemophilia mutations when  their sons 
have hemophilia. 
this inherited disease was common in the royal fami-
lies of europe, the sons, grandsons, and great grandsons of 
Queen Victoria (Fig. 9, c). the Queen herself did not suf-
fer from this illness, but it seems that she carried the mu-
tant gene. there is no evidence of hemophilia in any of her 
present living relatives. 
Maria Fedorovna (Princess Dagmar)
Ksenia Olga Nikolay II
blood stain
bone fragment №4-46
T.K. - P.
Kc.
on a shirt
16169 С
16169 Т
16169 C/Т
Fig. 6. Heteroplasmy at 
the 16169C/T locus in 
the mitochondrial (mater-
nal) lineages of Emperor 
Nicholas II
Nikolay I (1769-1855)
Nikolay (1831-1891)
Nikolay II (1868-1918)
Alexander II (1818-1881)
Alexander III (1845-1894)
Alexey (1904-1918) Dmitri  
(b. 1926)
Nikolay  
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Fig. 7. The paternal lineages of the Romanov family. The family members 
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In order to determine whether Alexandra Fedorovna or 
Prince Alexey carried any mutations in genes, all the exons 
and the intron-exon boundaries of F8 or F9 genes  were am-
plified using  multiplex amplification reaction and then se-
quenced by massively parallel sequencing. Miniscule amounts 
of DnA and its high level of degradation  required special 
procedures for the identification of the nucleotide sequences 
that included the 26 exons of the F8 gene and the 8 exons of 
Table 6. Methods used in screening for mutations of the F8 and F9 genes [49]
Stage of analysis Special procedures reagents and methods
Multiplex Pcr-
amplification of the 
Factor VIII gene, F8 
(26 exons) and Factor 
IX, F9 gene (8 exons),
located on the 
X-chromosome
extracts that were shown to be free of contamina-
tion (in analysis of mtDnA) were used further for 
nuclear gene study. negative controls were used: 
Pcr-amplification of “empty” extracts (all  DnA 
extraction steps were performed, , but  with no bone 
specimen material added in the course of the extrac-
tion procedures) and Pcr amplification without  
addition of  extracted DnA.
~ 210 pairs of primers were designed for multiplex Pcr amplification 
of short overlapping sequences (< 200 bp) that would cover all the 
exons and the intron-exons boundaries of the F8 and F9 genes. the 
primers were grouped into 14 sets for the F8 gene and 3 sets for the 
F9 gene, with each set consisting of 7 to 30 pairs of primers. About 100 
pg of human DnA (~ 16-17 diploid genomes) were used for the initial 
multiplex Pcr.
Sequencing
Sequencing of the blood clotting factors genes F8 
and F9 was done in parallel with the mitochondrial 
genome to have a control for contamination and 
unequivocal identification of the sample.
Individual Pcr-fragments were excised and purified from a 2.5 % 
agarose gel and then sequenced using two strategies.  One involved 
mixing the Pcr products in equimolar amounts and using them for 
massively parallel sequencing (Illumina GA). the other approach 
involved the direct sequencing of individual Pcr-products on a 
96-capillary sequencer 3730xl DnA analyzer (Applied Biosystems).
Genotyping of the 
identified F9 gene 
mutation 
8 independent amplifications of the n7 sample 
(empress Alexandra) were performed. For other 
bone samples, 2 to 7 independent amplifications 
were analyzed for each sample. 
the mutation that was initially found during the DnA analysis of 
Skeleton n7 was verified by sequencing of  ultra-short amplicons (63 
bp and 83 bp) obtained with specially designed  primers.
the same primers were used to amplify  DnA from bone specimens  
n146 (Prince Alexey) and n3, n5, n6, n147 (nicolas II’s and 
Alexandra’s daughters). 
Analysis of splicing 
products
the amplified fragment with mutations in  F9 gene was cloned into 
the pet01 exontrap vector (MoBitec). After verifying the sequence 
of the recombinant molecule, it was used for cell culture transfection. 
cDnA derived  from transfected cell cultures was 
amplified, and the Pcr product library was sequenced (Illumina GA).
the spliced sequences were identified in 812,114 reads. 99.982 % of 
the transcripts were spliced at the mutant site, and only 0.018 % were 
spliced at the wild-type site.
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Fig. 8. Analysis of the sex chromosome and autosomal  STR-markers in 
DNA extracted from bone specimens [45] 
the F9 gene (the strategy and methods used in this study are 
described in table 6).  
the first step was to analyze DnA extracts from Alex-
andra that showed no contamination based on the results of 
mtDnA and autosomal Str-marker analysis. Amplification 
of the F8 gene and the 8 exons of the F9 gene was performed 
in parallel with the amplification of mtDnA that was used as 
a control and for accurate identification of the sample. non-
synonymous substitutions or insertion-deletion mutations 
were not found in  either the F8 or F9 gene.  However, we 
detected  a single nucleotide substitution of A =>G at an in-
tron-exon boundary and, 3 nucleotides before the start of the 
4th exon of the F9 gene (referred to as IVS3-3A>G according 
to standard nomenclature). As expected for a heterozygote 
carrier, Alexandra Fedorovna carried  both mutant and wild-
type sequences. Alexey  bear only the mutant allele, meaning   
that he was homozygous for this mutation, while one of his 
sisters (presumably Anastasia) was a heterozygous carrier of 
the mutation. the other sisters did not carry the mutant al-
leles; they were homozygous carriers of the wild-type allele 
(Fig. 9) [49].  
Bioinformatic analysis showed that the IVS3-3A>G muta-
tion activates the cryptic splicing acceptor site, which leads to 
frame-shift during the translation of the F9 gene mrnA and 
the appearance of a premature stop-codon (Fig. 9, а). 
the effect of this mutation on rnA splicing was studied   
by expressing the mutant fragment of the F9 gene in a cell 
culture using a specialized recombinant exontrap vector (Mo-
Bitec). We found that 99.98 % of transcripts were generated 
by splicing at the mutant site. Less than 1% of the activity 
of Factors VIII or IX leads to severe manifestations of he-
mophilia [50]. Population database searches and genotyping 68 | ActA nAturAe |  № 3 2009
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of a large cohort of unaffected  individuals did not reveal   
any IVS3-3A>G affected individuals, while we found three 
reported hemophilic patients with the same substitution in   
Hemophilia B databases (table 4).  All three had reduced ac-
tivity of  Factor IX (≤1 % of normal activity) and manifested 
severe hemophilia symptoms. these data confirmed  that 
the  hereditary illness in Queen Victoria’s lineage, includ-
ing Prince Alexey, was a severe form of hemophilia B caused 
by a rare mutation in the F9 gene [49]. Since none of Queen 
Victoria’s ancestors were known to have hemophilia, it can 
be assumed that this mutation was acquired de novo during 
gametogenesis in one of her parents. 
F9 WT а
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EXON 4
EXON 4
F9 MUTANT
gene
gene
cDNA
cDNA
protein
WT
MUT
protein
...AAG CAG TAT GTT G gtaagca….
...AAG CAG TAT GTT G gtaagca….
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…ctatctcaG AT ATG GAG ATC AGT GTG AGT CCA ATC  CAT GTT  TTA...
…AAG CAG TAT GTT GAT GGA GAT CAG TGT GAG TСС AAT ССA TGT TTA...
…AAG CAG TAT  GTT GAG ATG GAG ATC AGT GTG AGT  CCA ATC  CAT  GTT  TAA...
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Fig. 9. Hemophilia in 
the royal families of 
Europe: a – the point 
mutation in the F9 
gene of the blood-
clotting factor, that 
creates an alternative 
splicing site [49]; 
b – the pedigree 
demonstrating the 
inheritance of hemo-
philia from Queen 
Victoria to her 
descendants; c – se-
quencing chromato-
grams of the F9 gene 
sequence obtained 
during the analysis of 
DNA extracted from 
bone remains
CONCLuSION
the methods of DnA analysis developed and widely used in 
recent years allow experimental identification and reconstruc-
tion of DnA nucleotide sequences extracted from biological 
samples preserved for prolonged periods of time in natural 
conditions or have been subjected to DnA and its constitu-
ent molecules damage. the possibility of a successful study 
of such samples is provided by the use of novel sequencing 
strategies, novel methods for extracting and purifying DnA,   
specially equipped facilities, variety of control experiments, 
and additional methods of data analysis that prevent inter-
pretation errors in the data. All this  factors have contributed reVIeWS
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to the extraction of genetic information from organisms that 
have disappeared tens of thousands of years ago, and to the 
reconstruction of evolutionary events, which was hitherto 
unachievable in experimental study. these findings opened 
new possibilities for precise molecular genetic analysis of se-
verely damaged and decayed DnA, which has already raised 
the standard of applied procedures in forensic medicine. the 
results reviewed in this paper could not have been obtained 
without the development of novel DnA technologies that can 
now be incorporated into the everyday routines of fundamen-
tal and applied research, making them more reliable, fast and 
informative, as well as lowering costs.  
The study was supported by  the Russian Federal Agency for 
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by the  Program “Biodiversity” of Presidium of  Russian 
Academy of Sciences.
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